Last edition
News about Global Pharma
Biocon Biologics and Civica to Expand Insulin Aspart Access in US
Civica will commercialize the medicine for patients in the United States, after completion of development work and clinical trials. No technology transfer is involved in the agreement.
Global Pharma | 10/03/2025 | By Aishwarya | 441
Sun Pharma to Acquire Checkpoint Therapeutics
Checkpoint has received approval from the US Food & Drug Administration (FDA) for UNLOXCYT™ (cosibelimab-ipdl) for the treatment of adults with metastatic cutaneous squamous cell carcinoma (cSCC) or locally advanced cSCC who are not candidates for curative surgery or curative radiation.
Global Pharma | 10/03/2025 | By Aishwarya | 232
Moleculin Announces Additional Annamycin Patent Allowances
Moleculin Biotech, Inc., a late-stage pharmaceutical company focused on developing innovative treatments for hard-to-treat cancers and viruses, has received a Notice of Intent to Grant for its European patent application covering the formulation of liposomal Annamycin.
Global Pharma | 07/03/2025 | By Manvi | 201
Zydus Secures Final Approval from USFDA for Dasatinib Tablets in Multiple Doses
Zydus Lifesciences has received USFDA approval to manufacture Dasatinib tablets 20 mg, 50 mg, 70 mg, 80 mg, 100 mg, and 140 mg for treating Philadelphia chromosome-positive leukaemias. These tablets will be produced in the company’s Ahmedabad facility.
Global Pharma | 07/03/2025 | By Manvi | 440
Enzene Bags EU GMP Certification for its Facilities in India
Enzene is a fully integrated, end-to-end CDMO with services spanning discovery, development, and commercial supply, operating integrated sites in Pune (India) and New Jersey (USA).
Global Pharma | 07/03/2025 | By Aishwarya | 493
Astellas and YASKAWA to Establish Joint Venture Focused on Cell Therapy Manufacturing
The planned joint venture will leverage Astellas' expertise in R&D and manufacturing for cell therapy and the dual arm robot ‘Maholo’, developed by YASKAWA's subsidiary, Robotic Biology Institute.
Global Pharma | 06/03/2025 | By Aishwarya | 319
Syntegon to Showcase New Filling Solution for RTU Syringes at Interphex
A new robotic handling unit is also at the heart of Syntegon’s patented Settle Plate Changer. It automates viable monitoring during sterile product filling.
Global Pharma | 06/03/2025 | By Aishwarya | 561
Scinai Immunotherapeutics Ltd. announced that it has entered into a Standby Equity Purchase Agreement (the SEPA) with YA II PN, Ltd. (Yorkville), a fund managed by Yorkville Advisors Global, LP.
Global Pharma | 05/03/2025 | By Manvi | 256
Senores Pharmaceuticals Strengthens Global Presence with New USFDA Approvals
The acquisition includes 13 ANDAs that have already received approval from the US Food and Drug Administration (USFDA) and one ANDA that is currently pending approval.
Global Pharma | 05/03/2025 | By Aishwarya | 684
Bhimrao Jadhav Joins NATCO Pharma as Senior VP of Formulations Operations
Jadhav holds a Bachelor’s degree in Pharmacy and brings over 30 years of experience in pharmaceutical operations management.
Global Pharma | 05/03/2025 | By Aishwarya | 1111
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy